Karyopharm - oncology

It seems that the new head of IR’s main job is to police the
Public forum to scrub negative posts. Does one have to attend Harvard biz school to learn such a savvy skill ?? Or perhaps he was hired to polish the CEO’s shoes with the two buckets on them. He needs to buckets on each foot to keep all of his bullshit inside the heel to stand on.
 






3:1 reverse splits always evoke confidence in the financial well being and executive leadership of a company. What's nuts is KPTI would still be in jeopardy of falling below a dollar as a new SP of 1.80 does not give us much wiggle room...

I'm sure the Argot people, or our new CFO, or our new investor relations person will have some clever reply on here as to why everything is going as planned, MF will save us, and Wall Street is blind to our enterprise value potential.
This is brilliant and something no one in the executive team is talking about! Does anyone really trust or believe anything 'they' say at this point? I'm finding it difficult to recall one proclamation they got right. How refreshing would it be if they were just truthful? Unfortunately that is not the Amgen way. Keep the rank and file in the dark for as long as you can...
 






This is brilliant and something no one in the executive team is talking about! Does anyone really trust or believe anything 'they' say at this point? I'm finding it difficult to recall one proclamation they got right. How refreshing would it be if they were just truthful? Unfortunately that is not the Amgen way. Keep the rank and file in the dark for as long as you can...
The four
Pillars of prosperity. Anyone have a paper towel to wipe the egg off our CEO’s face?? This stock is head to its final resting place sooner than later. I sure hope the SEC or DOJ look into how it happened and who reaped the most out of its demise. I think we should all commence and writing campaign to wake some folks up about little dicky and the ashes of this now fallen micro cap
 












Rearranging deck chairs on the Titanic...


Karyopharm increases authorized shares, approves reverse split By Investing.com

https://www.investing.com/news/sec-...ed-shares-approves-reverse-split-93CH-3841331
Anywhere from 5:1 to 15:1 reverse split...my goodness. This is already a diluted stock now looking to grow to 800 million outstanding shares...you have got to me kidding. There is absolutely nothing that will get us out of this hole. Seli, even if it gets MF and Endo will never generate enough revenue and there is nothing in our pipeline that suggests 'blockbuster' status. This is the last death gasp for this company.
 












Rearranging deck chairs on the Titanic...


Karyopharm increases authorized shares, approves reverse split By Investing.com

https://www.investing.com/news/sec-...ed-shares-approves-reverse-split-93CH-3841331
The charlatan CEO gets lease on life for a few more quarters. Just enough proper to finally hang himself. Cannot wait to see him hang metaphorically of course. It is a well deserved ode to “you get what you earn”. Such ineptitude and indolence as well as cavalier arrogance have been exposed for long time.
 






To fellow employees, we listened to their bullshit too too long. All those “town hall” special meetings emitting bullshit and bull shit. All for the sake of our leader milking the shit out of comp pay with his lackeys playing back up in the echo chamber of doom. How do we still stand with this leadership team. Even children of abusive parents get protection from the state. Where is the SEC ?? Where are the bloodhound lawyers chomping for any wife of red meat?? It is all right here tucked away under a disguise of servitude
 






If ANYONE thought MF and Endo are actually going to have any true upside they would take us off the board now. We are distressed, about to execute a 5:1 or 15:1 reverse split to buy time from getting delisted, so why not offer us $15 a share before the false, inflated share price goes to $3 - $10? Perhaps 'they' know there is little value, and the share prices will merely fall back to a few dollars quickly and they can get us even cheaper? Either way, no one is interested in Seli by the mere fact no one is offering us anything at all. This would be the opportune time for a big pharma's to pick up a molecule on the cheap...yet no one is biting, and is why most companies shelved their SINE platforms...they just don't work all that well and have high toxicities...but we already know that.
 






If ANYONE thought MF and Endo are actually going to have any true upside they would take us off the board now. We are distressed, about to execute a 5:1 or 15:1 reverse split to buy time from getting delisted, so why not offer us $15 a share before the false, inflated share price goes to $3 - $10? Perhaps 'they' know there is little value, and the share prices will merely fall back to a few dollars quickly and they can get us even cheaper? Either way, no one is interested in Seli by the mere fact no one is offering us anything at all. This would be the opportune time for a big pharma's to pick up a molecule on the cheap...yet no one is biting, and is why most companies shelved their SINE platforms...they just don't work all that well and have high toxicities...but we already know that.
The 15:1 is telling. I’m assuming they know that the stock will lose at least 70-90 percent of its value when bankruptcy is declared. 5:1 wouldn’t be enough to still keep it above $1 after that.
 






To fellow employees, we listened to their bullshit too too long. All those “town hall” special meetings emitting bullshit and bull shit. All for the sake of our leader milking the shit out of comp pay with his lackeys playing back up in the echo chamber of doom. How do we still stand with this leadership team. Even children of abusive parents get protection from the state. Where is the SEC ?? Where are the bloodhound lawyers chomping for any wife of red meat?? It is all right here tucked away under a disguise of servitude

'Little Dickey engaged in a scheme to deceive investors about Karyopharm’s development of an investigational drug to artificially inflate and maintain the price of Karyopharm’s stock and to attract new investors.'

SEC.gov | Welcome to SEC Tips, Complaints, and Referrals
 
























I’ve invested in this since 2019. It’s clear that this management team has no clue how much money they really need and once they get a new tranche of dilutive cash, they continue on the same burn rate until more is inevitably needed. Changes of disease targets, delays of trials, dilutions, high interest debt, and reverse splits.
 












I’ve invested in this since 2019. It’s clear that this management team has no clue how much money they really need and once they get a new tranche of dilutive cash, they continue on the same burn rate until more is inevitably needed. Changes of disease targets, delays of trials, dilutions, high interest debt, and reverse splits.
quite a resume builder isn't it ?? At this rate,he may end up with the credentials to become the next CEO of Canada